[HTML][HTML] Transposons: moving forward from preclinical studies to clinical trials

K ChuahMarinee - Human gene therapy, 2017 - liebertpub.com
Transposons have emerged as promising vectors for gene therapy that can potentially
overcome some of the limitations of commonly used viral vectors. Transposons stably …

Transposons: Moving Forward from Preclinical Studies to Clinical Trials

J Tipanee, T VandenDriessche… - Human Gene …, 2017 - researchportal.vub.be
Transposons have emerged as promising vectors for gene therapy that can potentially
overcome some of the limitations of commonly used viral vectors. Transposons stably …

Transposons: Moving Forward from Preclinical Studies to Clinical Trials

J Tipanee, T Vandendriessche, MK Chuah - Human Gene Therapy, 2017 - hero.epa.gov
Transposons have emerged as promising vectors for gene therapy that can potentially
overcome some of the limitations of commonly used viral vectors. Transposons stably …

[引用][C] Transposons: Moving Forward from Preclinical Studies to Clinical Trials

J Tipanee, T VandenDriessche, MK Chuah - Human Gene Therapy, 2017 - cir.nii.ac.jp
Transposons: Moving Forward from Preclinical Studies to Clinical Trials | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

Transposons: Moving Forward from Preclinical Studies to Clinical Trials

J Tipanee, T VandenDriessche… - Human gene …, 2017 - pubmed.ncbi.nlm.nih.gov
Transposons have emerged as promising vectors for gene therapy that can potentially
overcome some of the limitations of commonly used viral vectors. Transposons stably …

Transposons: Moving Forward from Preclinical Studies to Clinical Trials

J Tipanee, T VandenDriessche, MK Chuah - Human Gene Therapy, 2017 - liebertpub.com
Transposons have emerged as promising vectors for gene therapy that can potentially
overcome some of the limitations of commonly used viral vectors. Transposons stably …

Transposons: Moving Forward from Preclinical Studies to Clinical Trials.

J Tipanee, T VandenDriessche, MK Chuah - Human Gene Therapy, 2017 - europepmc.org
Transposons have emerged as promising vectors for gene therapy that can potentially
overcome some of the limitations of commonly used viral vectors. Transposons stably …